Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

The document concludes that understanding the sebaceous gland's development and function is key to addressing related skin diseases and aging effects.

Scalp massages may help stabilize or regrow hair in people suffering from hair loss, regardless of age, gender, or use of other treatments.

The lotion with equol, dihomo-γ-linolenic acid, and propionyl-l-carnitine was effective in reducing hair loss in men and women.

Minoxidil helps prevent stress-caused hair loss in mice.

Accurate diagnosis and personalized treatment are crucial for managing women's hair loss.

A witch-hazel-based 5% minoxidil solution is effective and safe for women with hair loss who didn't respond to regular minoxidil, especially if they're sensitive to propylene glycol.

A patient with Werner syndrome showed a range of aging-like symptoms and metabolic issues, underscoring the need for early detection and treatment.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Finasteride use in young men with hair loss is linked to sexual dysfunction.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

AA-PRP injections effectively increase hair count and thickness for male pattern hair loss.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.